LCM
Laurion Capital Management Portfolio holdings
AUM
$867M
This Quarter Return
+5.58%
1 Year Return
+5.19%
3 Year Return
+14.26%
5 Year Return
+18.43%
10 Year Return
+26.97%
AUM
$3.26B
AUM Growth
+$3.26B
(+32%)
Cap. Flow
+$536M
Cap. Flow
% of AUM
16.41%
Top 10 Holdings %
Top 10 Hldgs %
43.82%
Holding
817
New
197
Increased
58
Reduced
96
Closed
383
Top Buys
| 1 |
Viatris
VTRS
|
$435M |
| 2 |
iShares iBoxx $ High Yield Corporate Bond ETF
HYG
|
$249M |
| 3 |
Intel
INTC
|
$91.7M |
| 4 |
Alibaba
BABA
|
$85.7M |
| 5 |
International Flavors & Fragrances
IFF
|
$76.4M |
Top Sells
| 1 |
SPDR Gold Trust
GLD
|
$79.7M |
| 2 |
Exxon Mobil
XOM
|
$75.1M |
| 3 |
Citigroup
C
|
$74.2M |
| 4 |
Chevron
CVX
|
$58.5M |
| 5 |
Expedia Group
EXPE
|
$54.4M |
Sector Composition
| 1 | Healthcare | 33.17% |
| 2 | Technology | 9.29% |
| 3 | Industrials | 9.22% |
| 4 | Consumer Discretionary | 8.92% |
| 5 | Energy | 7% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
126
Praxis Precision Medicines
PRAX
$958M
| $2.75M | 0.02% | +50,000 | New | +$2.75M |
|
127
GoodRx Holdings
GDRX
$1.51B
| $2.7M | 0.02% | 67,000 | – | – |
|
128
Amazon
AMZN
$2.44T
| $2.7M | 0.02% | 829 -14,909 | -95% | -$48.6M |
|
129
Builders FirstSource
BLDR
$15.3B
| $2.68M | 0.02% | +65,615 | New | +$2.68M |
|
130
Cambium Networks
CMBM
$21.5M
| $2.67M | 0.02% | 106,310 +3,435 | +3% | +$86.1K |
|
131
Protagonist Therapeutics
PTGX
$3.67B
| $2.62M | 0.02% | +130,158 | New | +$2.62M |
|
132
New Fortress Energy
NFE
$675M
| $2.61M | 0.02% | +48,698 | New | +$2.61M |
|
133
Galecto
GLTO
$4.21M
| $2.59M | 0.02% | +207,552 | New | +$2.59M |
|
134
Option Care Health
OPCH
$4.65B
| $2.59M | 0.02% | 165,347 +34,927 | +27% | +$546K |
|
135
PTC
PTC
$25.6B
| $2.54M | 0.02% | +21,234 | New | +$2.54M |
|
136
American Well
AMWL
$111M
| $2.53M | 0.02% | 100,000 | – | – |
|
137
Mohawk Industries
MHK
$8.24B
| $2.48M | 0.02% | 17,570 -142,430 | -89% | -$20.1M |
|
138
TJX Companies
TJX
$152B
| $2.45M | 0.02% | 35,855 -151,745 | -81% | -$10.4M |
|
139
Lennar Class B
LEN.B
$32.9B
| $2.45M | 0.02% | 40,008 | – | – |
|
140
Goldman Sachs
GS
$226B
| $2.44M | 0.02% | 9,250 +9,075 | +5,186% | +$2.39M |
|
141
4D Molecular Therapeutics
FDMT
$288M
| $2.4M | 0.02% | +58,000 | New | +$2.4M |
|
142
GE Aerospace
GE
$292B
| $2.4M | 0.02% | +222,100 | New | +$2.4M |
|
|
PXD
143
DELISTED
Pioneer Natural Resource Co.
PXD
| $2.39M | 0.02% | +20,965 | New | +$2.39M |
|
144
Curis
CRIS
$20.9M
| $2.37M | 0.02% | +289,438 | New | +$2.37M |
|
145
S&P Global
SPGI
$167B
| $2.25M | 0.02% | +6,829 | New | +$2.25M |
|
146
Altria Group
MO
$113B
| $2.23M | 0.02% | 54,320 +9,251 | +21% | +$379K |
|
147
Schlumberger
SLB
$55B
| $2.18M | 0.02% | 100,000 +79,200 | +381% | +$1.73M |
|
|
EVOP
148
DELISTED
EVO Payments, Inc. Class A Common Stock
EVOP
| $2.13M | 0.02% | +78,958 | New | +$2.13M |
|
149
Pebblebrook Hotel Trust
PEB
$1.32B
| $2.11M | 0.02% | +112,262 | New | +$2.11M |
|
150
Beam Therapeutics
BEAM
$1.66B
| $2.04M | 0.02% | 25,000 | – | – |
|